CochLear Ltd. Unsponsored ADR (CHEOY)
(Delayed Data from OTC)
$100.72 USD
-0.66 (-0.65%)
Updated Aug 28, 2024 12:51 PM ET
5-Strong Sell of 5 5
F Value B Growth A Momentum D VGM
CochLear Ltd. Unsponsored ADR (CHEOY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$N/A | $N/A | $N/A | N/A% |
Price Target
CochLear Ltd. Unsponsored ADR does not have any price target set by analysts.
Analyst Price Targets ()
Broker Rating
CochLear Ltd. Unsponsored ADR currently has an average brokerage recommendation (ABR) of 4.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 4.33 a month ago based on three recommendations.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CHEOY.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 2 | 1 |
ABR | 4.00 | 4.00 | 4.33 | 4.33 | 3.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/16/2024 | Not Identified | Not Identified | Not Available | Hold |
8/16/2024 | UBS | Laura Sutcliffe | Strong Sell | Strong Sell |
6/3/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
5/24/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 4.00 |
ABR (Last week) | 4.00 |
# of Recs in ABR | 4 |
Average Target Price | NA |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 149 of 253 |
Current Quarter EPS Est: | NA |